Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MDT has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
MDT stock price ended at $86.34 on Friday, after rising0.71%
The Medtronic PLC stock price increased by 0.71% on the last trading day (20 Jun 2025), rising from 86.14 to 86.34. Throughout the last trading session, the stock experienced a fluctuation of 0.81% , ranging from a day low of $85.73 to a day high of 86.425. The price has declined in 3 of the last 10 days, resulting in a total change of -0.76% during this period. On the last day, trading volume increase by 4.57M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 13.09M shares were traded, amounting to approximately 1.13B.
MDT Technical Signals
MDT(Medtronic PLC Corp) has 3 buy signals and 2 sell signals now. The current trend is consolidation starting from 2025-06-16. The total price change during this trend is -1.80%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of MDT over the last 5 trading days is 744.50M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
MDT Moving Average Analysis
Medtronic PLC's overall moving average trend leans more bearish as of Monday, June 23, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $89.23081333333334, and $90.51433333333334. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $85.07785333333334, and $83.79433333333334. A break-down below any of these levels will issue sell signals.
MDT Short Selling Analysis
The short sale ratio of Medtronic PLC(MDT) as of 17 Jun 2025 is 10.88%, dropping from last trading day. With decreasing price from 87.92 to 86.17. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
2
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
2.017
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.676
Bullish
Moving Average
Price crosses above 250-day SMA
--
Bullish
2 Bearish Signals
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-0.66
Bearish
Moving Average
5-day SMA crosses below 200-day SMA
--
Bearish
MDT Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Medtronic PLC(MDT), our algorithm predicts MDT's 1-month price at $93.01, with an 7.72%upwardshift. Using a similarity score up to 95.03%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Medtronic PLC (MDT.N) stock, as of Sunday, June 22, 2025 , forecasts a 7.72% change over the next month, based on its high correlation with CVLT.O stock patterns. The similarity between their price movements over the analyzed periods is 95.03%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
MDT
No Data
CVLT
Up: 7.72%Similarity: 95.03%
Name
Similarity
Up/Down
CVLT.O
95.03%
+7.72%
AXON.O
94.64%
+11.88%
TRGP.N
94.63%
-1.15%
NICE.O
94.23%
-4.42%
DVA.N
93.98%
+2.00%
R.N
93.93%
+2.90%
VIRT.O
93.65%
-5.00%
KELYA.O
93.38%
+2.30%
ALX.N
93.38%
-6.85%
NKE.N
93.33%
-26.33%
MDT Seasonality Analysis
Based on MDT's historical stock price data across all years, the probability of a positive return in June is53.33%, suggesting it maybe an ideal month to invest in MDT. In contrast,Julyoffers the highest probability of positive returns at76.92%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Medtronic PLC (MDT.N) stock in July has the highest probability of a positive return (76.92%), while September has the lowest probability (23.08%).
Performance Seasonality
The chart shows Medtronic PLC. (MDT)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Medtronic PLC (MDT.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MDT has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Medtronic PLC (MDT.N) stock in a year?
The radar chart shows that buying Medtronic PLC (MDT.N) stock in July has the highest probability of a positive return (76.92%), while September has the lowest probability (23.08%).
How has Medtronic PLC. (MDT)'s stock price performed over the past three years?
MDT's stock price rose by 5.26% in 2023,decreased by -4.33% in 2024, and went up by 8.48% in 2025.
Bearish technical signals of MDT include: MOM_10 < 0, 5-day SMA crosses below 200-day SMA.
Is MDT a buy based on overall technical signals summary?
MDT has 3 buy signals and 2 sell signals now. Overall the technical rating for MDT is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of MDT.
What is the trend of Medtronic PLC (MDT)'s moving average?
Medtronic PLC's overall moving average trend leans more bearish as of June 23 2025, with 2 negative signals and 2 positive signal.
What is price prediction for MDT stock next month?
The price prediction chart for Medtronic PLC (MDT.N) stock, as of June 22 2025, forecasts a 7.72% change over the next month, based on its high correlation with CVLT stock patterns. The similarity between their price movements over the analyzed periods is 95.03%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for MDT Stock?
### **Price Prediction for MDT Stock in 2025**
The price prediction for Medtronic (MDT) stock in 2025 is **$92.50**.
**Reasons**:
1. Strong Q4 and FY2025 results with organic revenue growth of 5% and adjusted EPS up 11%, showcasing solid execution across its portfolio.
2. The company's strategic move to spin off its diabetes business aims to enhance focus and margins, potentially unlocking hidden value for shareholders.
3. Analysts maintain a "Moderate Buy" consensus with a mean price target of $93.83, reflecting confidence in MDT's long-term growth prospects.
{RATING:symbol=MDT, type=0}
What is price prediction 2030 for MDT Stock?
The price prediction for Medtronic (MDT) stock by 2030 is approximately $120 per share. This forecast is based on strong fundamentals, including solid earnings growth and a strategic focus on core markets. The spin-off of the diabetes division is expected to enhance margins and drive long-term value.